Collplant Holdings Ltd (CLGN)

Trade CLGN now with
9/14/2020 7:21:36 AM CollPlant Inks Deal For Distribution Of Vergenix Flowable Gel Product In Six CIS Countries
8/28/2020 7:04:40 AM CollPlant Q2 Revenues Of $823,000, 36% Increase From Last Year
5/27/2020 7:08:56 AM CollPlant Biotechnologies Q1 Loss Per Share $0.24; Non-GAAP Loss Per Share $0.21
4/1/2020 7:08:32 AM CollPlant Biotechnologies FY Operating Loss $7.6 Mln Vs Loss $4.2 Mln Last Year
2/14/2020 7:07:59 AM CollPlant Biotechnologies Enters Definitive Agreements For Up To $4.45 Mln
2/10/2020 7:11:28 AM CollPlant Names Roger Pomerantz As Chairman Of Board Of Directors
12/19/2019 7:00:00 AM CollPlant Publishes Letter to Shareholders (Press Release)
11/29/2019 7:02:45 AM CollPlant Q3 Loss Per Share $0.69; Adj Loss Per Share $0.41
9/26/2019 7:07:09 AM CollPlant Q2 Comprehensive Loss $1.5 Mln Or $0.33/Shr Vs Loss Of $1.7 Mln Or $0.36/Shr Last Year
6/20/2019 8:11:21 AM CollPlant Holdings Ltd. Changes Names To CollPlant Biotechnologies Ltd
6/4/2019 7:19:42 AM CollPlant Says Clinical Results From Advanced Wound Care Product VergenixFG To Be Presented At EWMA
5/30/2019 7:03:31 AM CollPlant Q1 Comprehensive Loss $2.0 Mln Or $0.01/Shr Vs Loss Of $2.2 Mln Or $0.01/Shr Last Year
5/22/2019 8:59:37 AM CollPlant Launches New HQ And R&D Center In Israel
2/19/2019 6:07:13 AM CollPlant Reports Approval Of Its RhCollagen Manufacturing Facility By European Union Notified Body
2/4/2019 6:01:46 AM CollPlant Appoints Jonathan Rigby As Chairman Of Board
11/29/2018 8:10:52 AM CollPlant Q3 Revenues $224,000 Or NIS 813,000
11/12/2018 6:02:31 AM CollPlant Announces Closing Of Global Licensing And Commercialization Agreement With United Therapeutics